Vol 11, No 2 (2007)
Other materials agreed with the Editors
Published online: 2007-05-18

open access

Page views 574
Article views/downloads 6120
Get Citation

Connect on Social Media

Connect on Social Media

The possibilities of proteinuria reduction in hypertensive patients in light of large clinical trials

Michał Myśliwiec, Alicja Rydzewska-Rosołowska
Nadciśnienie tętnicze 2007;11(2):164-167.

Abstract

Proteinuria may be of glomerular or tubular origin but may be also caused by endothelial damage. Hypertension is a known cause of proteinuria, especially microalbuminuria. This is associated with a greater cardiovascular mortality. This review is dedicated to the possibilities of reducing proteinuria in hypertensive patients. It concisely states the results of large up to date clinical trials. A proteinuric hypertensive patient should have the best possible blood pressure control. The drugs of choice are ACE-inhibitors and AT1-blockers, especially in combination.

Article available in PDF format

View PDF (Polish) Download PDF file